Samuel L. Aitken
Samuel L. Aitken
Verified email at mdanderson.org
Title
Cited by
Cited by
Year
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
JM Munita, SL Aitken, WR Miller, F Perez, R Rosa, LA Shimose, ...
Clinical Infectious Diseases 65 (1), 158-161, 2017
1062017
Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study
DN Shah, SL Aitken, LF Barragan, S Bozorgui, S Goddu, ME Navarro, ...
Journal of Hospital Infection 93 (3), 286-289, 2016
522016
Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients
F Foolad, SL Aitken, TL Shigle, A Prayag, S Ghantoji, E Ariza-Heredia, ...
Clinical Infectious Diseases 68 (10), 1641-1649, 2019
482019
Successful treatment of bloodstream infection due to metallo-β-lactamase-producing Stenotrophomonas maltophilia in a renal transplant patient
MF Mojica, CP Ouellette, A Leber, MB Becknell, MI Ardura, F Perez, ...
Antimicrobial agents and chemotherapy 60 (9), 5130-5134, 2016
462016
Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics
SL Aitken, ND Beyda, DN Shah, HR Palmer, TM Lasco, H Koo, KW Garey
Annals of Pharmacotherapy 48 (6), 683-690, 2014
452014
Real-life assessment of the safety and effectiveness of the new tablet and intravenous formulations of posaconazole in the prophylaxis of invasive fungal infections via …
FP Tverdek, ST Heo, SL Aitken, B Granwehr, DP Kontoyiannis
Antimicrobial agents and chemotherapy 61 (8), 2017
442017
Aerosolized ribavirin: the most expensive drug for pneumonia
RF Chemaly, SL Aitken, CR Wolfe, R Jain, MJ Boeckh
Transplant Infectious Disease 18 (4), 634-636, 2016
442016
Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia
SL Aitken, J Altshuler, DJ Guervil, EB Hirsch, LL Ostrosky-Zeichner, ...
International journal of antimicrobial agents 45 (5), 541-544, 2015
382015
High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production in Enterobacteriaceae Bloodstream …
SL Aitken, JJ Tarrand, LM Deshpande, FP Tverdek, AL Jones, ...
Clinical Infectious Diseases 63 (7), 954-958, 2016
372016
Whole-genome sequencing accurately identifies resistance to extended-spectrum β-lactams for major Gram-negative bacterial pathogens
SA Shelburne, J Kim, JM Munita, P Sahasrabhojane, RK Shields, ...
Clinical Infectious Diseases 65 (5), 738-745, 2017
362017
Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship
SL Aitken, VS Hemmige, HL Koo, NN Vuong, TM Lasco, KW Garey
Diagnostic microbiology and infectious disease 81 (1), 4-8, 2015
322015
Colonic immunopathogenesis of Clostridium difficile infections
C Darkoh, BP Turnwald, HL Koo, KW Garey, ZD Jiang, SL Aitken, ...
Clinical and Vaccine Immunology 21 (4), 509-517, 2014
322014
Development and validation of a Clostridium difficile health-related quality-of-life questionnaire
KW Garey, SL Aitken, L Gschwind, S Goddu, Y Xie, C Duff, F Barbut, ...
Journal of clinical gastroenterology 50 (8), 631, 2016
302016
Regional and seasonal variation in Clostridium difficile infections among hospitalized patients in the United States, 2001-2010
JR Argamany, SL Aitken, GC Lee, NK Boyd, KR Reveles
American journal of infection control 43 (5), 435-440, 2015
302015
Antifungal resistance: a concerning trend for the present and future
JA Hendrickson, C Hu, SL Aitken, N Beyda
Current infectious disease reports 21 (12), 1-8, 2019
272019
Use of ceftolozane/tazobactam in the treatment of multidrug-resistant Pseudomonas aeruginosa bloodstream infection in a pediatric leukemia patient
SL Aitken, DP Kontoyiannis, AM DePombo, MM Bhatti, FP Tverdek, ...
The Pediatric infectious disease journal 35 (9), 1040-1042, 2016
272016
In the endemic setting, Clostridium difficile ribotype 027 is virulent but not hypervirulent
SL Aitken, MJ Alam, M Khaleduzzaman, ST Walk, WL Musick, VP Pham, ...
Infection control and hospital epidemiology 36 (11), 1318, 2015
272015
Agricultural applications for antimicrobials. A danger to human health: An official position statement of the Society of Infectious Diseases Pharmacists
SL Aitken, TJ Dilworth, EL Heil, MD Nailor
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (4 …, 2016
252016
Pharmacodynamic analysis of daptomycin-treated enterococcal bacteremia: it is time to change the breakpoint
LM Avery, JL Kuti, M Weisser, A Egli, MJ Rybak, EJ Zasowski, CA Arias, ...
Clinical Infectious Diseases 68 (10), 1650-1657, 2019
232019
Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections.
PD Tamma, SL Aitken, RA Bonomo, AJ Mathers, D van Duin, CJ Clancy
Clinical Infectious Diseases: an Official Publication of the Infectious …, 2020
222020
The system can't perform the operation now. Try again later.
Articles 1–20